Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

New immunosuppressive approaches: oral administration of CD3-specific antibody to treat autoimmunity.

New immunosuppressive approaches: oral administration of CD3-specific antibody to treat autoimmunity. J Neurol Sci. 2008 Nov 15; 274(1-2):9-12.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.